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Abstract:
The aim was to assess whether the analysis of time-intensity curves obtained after microbubble contrast agent injection could differentiate inflammatory from fibrotic ileal strictures among patients with Crohn’s disease (CD). Sixty-five consecutive patients (40 male and 25 female; mean age ± SD, 42.2 years ± 12.22) with stricture of the terminal ileal loop from CD were scanned after microbubble injection. Time-intensity curves were obtained from quantitative analysis and peak enhancement, rise time, time to peak, area under the time-intensity curve (AUC), AUC during wash-in (AUCWI), and AUC during wash-out (AUCWO) were compared between patients with inflammatory vs patients with fibrotic strictures. Inflammatory (n=40) vs fibrotic strictures (n=25) differed (P<.05) in the peak enhancement, the wash-in rate, the wash-in perfusion index, AUC, AUCWI, AUCWO. The quantitative analysis of small bowel wall contrast enhancement after microbubble contrast agent injection may differentiate inflammatory from fibrotic ileal strictures in patients with CD.
 
Key words: Crohn - Microbubbles - Ultrasound - Fibrosis
Introduction
Crohn’s disease [CD] patients with ileal disease develop clinically apparent strictures - corresponding to a constant luminal narrowing with prestenotic dilatation or obstructive signs/symptoms without presence of penetrating disease (Annese et al. 2013) - in approximately 40% of cases (Cosnes et al. 2011) during the long-term course of the disease and approximately 60% of patients require surgery within 20 years after diagnosis (Peyrin-Biroulet et al. 2012). The differentiation of predominantly inflammatory bowel strictures from primarily fibrotic strictures is crucial since pharmacologic anti-inflammatory treatment  is indicated in the presence of inflammatory changes, whereas endoscopic dilation or surgical resection are required in the presence of fibrosis (Bettenworth et al. 2016). 
Ultrasound [US], computed tomography [CT] and magnetic resonance [MR] imaging allow to demonstrate the transmural and extra-intestinal extent of CD (Cheng et al. 1994; Parente et al. 2002) . Moreover, CT and MR imaging (Bodily et al. 2006; Martίnez et al. 2009; Sempere et al. 2005) and contrast-enhanced US [CEUS] (De Franco et al. 2012; Migaleddu et al. 2009; Quaia et al. 2016; Ripollés et al. 2009) are considered reliable imaging techniques in assessing the inflammatory activity of CD. Anyway CT and MR enteroclysis/enterography present a limited accuracy to differentiate mural fibrosis from inflammation (Prassopoulos et al. 2001), mainly because both fibrosis and active inflammation coexist within the bowel wall. On the other hand, high radiation dose exposition is produced if CT is repeated during a strict follow-up schedule as it is often requested in patients with CD. According to a recent study (Lenze et al. 2012) only a combination of MR-enteroclysis and US as well as a combination of 2-deoxy-2-[fluorine-18]fluoro- D-glucose integrated with computed tomography (18F-FDG PET/CT) and US resulted in a 100% detection rate of fibrotic strictures requiring surgery or endoscopic dilation therapy. Even more recently another study showed that PET/MR enterography may differentiate purely fibrotic strictures from mixed or inflammatory strictures while no significant differences between inflammation and fibrosis were observed on T2-weighted and diffusion-weighted MR images (Catalano et al. 2016).
CEUS may represent a valuable alternative to CT and MR imaging in the differentiation of bowel inflammatory strictures from mural fibrosis. Some previous studies have shown the capabilities of CEUS to differentiate inflammatory from fibrotic bowel lumen strictures (Bodily et al. 2006; Martίnez et al. 2009; Quaia et al. 2012; Ripollés et al. 2013). Anyway, in those previous studies a limited patient population was included and the quantitative analysis was performed on unlinearized scale of echo-signal intensity values which limit precision and reproducibility of analysis. 
The aim of the present study was to assess whether the analysis of time-intensity curves obtained after microbubble contrast agent injection could differentiate inflammatory from fibrotic ileal strictures among patients with CD.

Materials and Methods
Patients and US examination
This prospective observational study was approved by the ethics committee of our institute and written informed consent was obtained from all patients. 
During a 24-month period (from June 1st 2013 to June 1st 2015), we recruited all patients with a biopsy-proven diagnosis of CD who underwent CEUS. Inclusion criteria were: (1) CD with stricture of the terminal ileal loop as shown by cross sectional imaging (CT or MR enterography) – defined as lumen narrowing with proximal lumen dilation - or endoscopy – defined as persistent severe luminal narrowing by inability to pass the scope - within one month from CEUS; (2) thickness of the terminal ileal loop >3mm as measured on unenhanced US; (3) available histologic reference assessment for intestinal inflammation and fibrosis including endoscopy with serial deep mucosal biopsies or analysis of the gross surgical specimen of the terminal ileal tract no more than 1 month after CEUS; (4) availability of the inflammatory histologic score or mural fibrosis diagnosis based on the analysis of mucosal biopsies or gross surgical specimen.
Eighty patients were initially included in this study. Fifteen of these patients were finally excluded due to unfeasible intubation of the distal ileum at ileum colonoscopy (n=2); ileal disease not appreciable at US (n=2) corresponding to a wall thickness of the terminal ileal loop <3mm; involvement of ileal tracts other than the terminal tract (n=11). 
Therefore, sixty-five consecutive patients (40 male and 25 female; mean age ± SD, 42.2 years ± 12.22) with a diagnosis of CD with an history of CD of 1 – 10 years (mean, 6 years) and with ileum (n=56) or ileum and colon involvement (n=9), were finally included (Table 1). These patients were undergoing specific anti-inflammatory treatment based on biological drug (n=20 patients; infliximab, n=15; adalimumab, n=5), or biological drug and corticosteroids (n=30; infliximab, n=17 patients; adalimumab, n=13 patients) or corticosteroids only (n=15 patients). 
Each patient underwent an US examination of the terminal ileal loop to make the scanning consistent between different patients. After a fast of at least 6 hours the terminal ileal loop was scanned by a diagnostic radiologist with 10 years of experience in US of the abdomen and who was not blinded to pathologic results before and after intravenous administration of sulphur hexafluoride-filled microbubbles (SonoVue, Bracco, Milan, Italy) injected as a single bolus of 4.8mL into a peripheral vein of the arm (1-2 seconds in duration) followed by 10 mL saline 0.9% flush. 
US examination was conducted by iU22 xMATRIX Ultrasound System (Philips Healthcare, Bothell, WA) by using a broadband 256 elements linear-array transducer (L12-5, 5–12 MHz, 50 x 10 mm). This linear transducer was selected since it produces high-resolution rectangular-shaped images which are suitable for the following quantitation procedure. Before US contrast administration, the terminal ileal loop wall thickness (mm) was measured at the level of the anterior wall, the depth of the ileal loop was measured from the leading serosa edge of the anterior bowel wall up to the skin surface (cm), and the absolute extension of the ileal tract involved was measured from the beginning up to the end of the ileal tract involved by the thickening of the anterior bowel wall (cm). 
The CEUS examination was performed by setting all technical parameters at the same value: power modulated pulse inversion (PMPI) technology; mechanical index 0.08, dynamic range 65dB, 10-13 frames per second, echo-signal gain below noise visibility, signal persistence turned on and one focus below the level of the small bowel segment. One uncompressed Digital Imaging and Communications in Medicine (DICOM) multi-frame cine-clip (15 frames per second and 2 minutes in duration) was acquired while the patient was breathing and transferred to the picture archiving and communication system (PACS) of the radiology department.   

Image analysis
Immediately after scanning two radiologists visually analysed in consensus the digital cine-clips of each patient. The small bowel enhancement after microbubble contrast agent injection was scored as 0=absent/faint enhancement-lower than the adjacent mesenteric fat, 1=enhancement limited to the submucosa or 2=diffuse transmural enhancement. These readers were aware of the patients’ identification, clinical histories, biopsy results and other imaging findings. All readings were performed on a PACS–integrated workstation (19-inch TFT display, resolution 2560 x 1600 pixels) at a central location by using a proprietary software package (Ebit Sanita AET, Genoa, Italy). 
One reference radiologist (EQ) with 15 years abdominal CEUS  experience , performed a quantitative analysis of echo-power by using a proprietary software package (VueBox, Version 4.3, Bracco, Geneva, Switzerland) (Tranquart F et al. 2012). Three sessions of analysis, each of 3 days, were necessary to complete the analysis. To assess inter-reader variability, two other blinded independent readers (experience, 5 and 10 years in abdominal imaging and CEUS), performed quantitative analysis in a subgroup of 20 patients, selected by simple randomization.
Each digital cine-clip was transferred to an encrypted USB device and then to a computer (Intel, Pentium 4, Santa Clara, CA) connected to the PACS and was used for the quantitative analysis. If peristalsis-related movements were evident in the scanned volume, those frames which appeared off-site to the reader were virtually excluded from the quantitative analysis. Out-of-plane images and images preceding contrast arrival in the bowel wall were excluded from processing both by the reference radiologist and independent readers.
VueBox linearizes compressed DICOM JPEG images before curve-fitting and analysis through application of an antilog function within the linear range of the microbubble concentration versus video-intensity relation. In each image a manually-defined polygonal (4,100–40,110 pixels, mean 21,430 pixels) region of interest (ROI) was drawn encompassing the thickened ileal tract over the anterior wall avoiding the lumen, or over the entire bowel wall if the lumen was not visible, avoiding the mesentery and artifacts along the entire extension of the terminal ileum included in the field of view of the screen. A second ROI, serving as a potential internal reference, was drawn encompassing the adjacent mesentery and excluding the ileal wall. The US video-intensity was measured in linear arbitrary units expressing the mean ± SD video intensity of pixels comprised in each ROI. After automatic detection of microbubbles appearance on the scanned plane, time-intensity curves were fitted by using a nonlinear least-squares regression method to a proprietary lognormal model (Arditi et al. 2006; Hudson et al. 2009). The quality of fit between the echo power signal and the theoretical curve was quantified by the least-square method.
The following kinetic parameters were automatically calculated for each patient: peak enhancement, rise time (time to peak enhancement minus time at which the maximum slope tangent intersects the x-axis), time to peak enhancement, wash-in rate (maximum slope, tangent at the ascending part of the curve), wash-out rate (minimum slope, tangent at the descending part of the curve), wash-in perfusion index (AUCWI / rise time), area under the whole time-intensity curve (AUC), AUC during wash-in (AUCWI), and AUC during wash-out (AUCWO). Data outliers were included in the analysis. 

Reference standard
Endoscopy (probe CF-H180AI/L; Olympus, Hamburg, Germany) with examination of the large bowel and the terminal ileal loop was performed after bowel preparation using polyethylene glycol administered the previous day, and overnight fasting by one gastroenterologist with 30 years of experience. Immediately after the procedure, an endoscopic score was assigned according to the Crohn’s Disease Endoscopic Index of Severity (CDEIS) (Mary et al. 1989). 
Multiple deep mucosal biopsies (from 2 to 4) from the most inflamed area of the terminal ilael loop or the analysis of the surgical specimen of the terminal ileal loop obtained no more than 1 month after CEUS represented the reference standards. Using the histologic acute inflammatory score (Borley et al. 2000), a score up to a maximum of 13 on the basis of grades for mucosal ulceration (grade 0–3), edema (grade 0–3), and quantity (grade 0–3) and depth (grade 0–4) of neutrophilic infiltration was assigned by one of many pathologists (each with 10-20 years of experience). Bowel strictures were classified as predominantly fibrotic when abnormal depositions of collagens were identified in the edges of mucosal ulceration. 

Statistical Analysis
Statistical analysis was performed by a computer software package (Stata 13.1, Stata Corp, College Station, Texas, USA).  
Separate univariate logistic regressions were conducted to determine the relationship between each kinetic parameter (independent variables), and the existence of inflammatory stricture (dependent outcome variable). Multivariate logistic regression analysis was performed to identify those kinetic parameters that were potential independent predictors of outcome. The non-parametric Spearman’s sign rank correlation coefficient (ρ) was used to assess the strength of relationships between the visual score, kinetic parameters and endoscopic grading, and between the kinetic parameters measured in the terminal loop and the adjacent mesentery. The inter-reader agreement was assessed by intra-class correlation coefficient. 
Receiver operating characteristic (ROC) curves were constructed for those kinetic parameters which revealed a significant difference between inflammatory vs fibrotic strictures to determine the optimum cut-off values (DeLong et al. 1988). The method used to identify the better cut-off value corresponds to the measurement of the maximum of vertical distance of ROC curve from the point (x, y) on diagonal line (chance line) by maximizing sensitivity plus specificity across various cut-off points. For all tests a P value < .05 was considered to indicate a statistically significant difference.


Results
Ileal strictures were classified into (predominantly) inflammatory in 40 patients or fibrotic in 25 patients. The mean absolute extension of the small bowel segments involved in CD was 5cm (3 to 10cm) with a mean depth of 2.5cm (range 2-4cm) from the skin surface. 
Two patients presented with more than one ileal strictures as shown by cross-sectional imaging. Ten patients with a fibrotic strictures based on results of mucosal biospy underwent surgical resection of the terminal ileal loop and histologic analysis of the resected ileal tract confirmed a prevalently fibrotic pattern.
On visual analysis, patients with inflammatory strictures revealed a transmural contrast enhancement in all cases, whereas patients with fibrotic strictures revealed transmural (n= 19 patients) or submucosal (n = 4) or absent/faint contrast enhancement (n = 2). The correlation between visual score and endoscopy grading was not significant (ρ = …; p 0.55). 
Table 2 shows the results of the quantitative analysis regarding different kinetic parameters in patients with an inflammatory or fibrotic strictures (Figure 1). The AUC was related to the endoscopic grading (ρ=0.77; P=0.03). The non-parametric Spearman correlation coefficient between the kinetic parameters measured in the terminal loop and in the adjacent mesentery ranged between 0.113 to 0.42 (P=0.21). 
Inflammatory strictures differed from fibrotic strictures in the peak enhancement, the wash-in rate, the wash-in perfusion index, AUC, AUCWI, AUCWO (Figure 2 and Figure 3). The quality of fit (expressed as a percentage) between the echo power signal and the theoretical lognormal curve before and after treatment was 93.76 ± 4.82 and 88.93 ± 8.33 in responders, and  96.26 ± 2.32 and 82.47 ± 29.29 in non-responders. 
Peak enhancement, rise time, time to peak enhancement, wash-in rate and wash-in perfusion index were not found predictors of inflammatory stricture on univariate analysis, while wash-out rate, AUC, AUCWI and AUCWO were found predictors of therapeutic outcome (P=0.02 – 0.04). No kinetic parameter was found independent predictor of therapeutic outcome on multivariate logistic regression (P=0.1 – 0.37). 
The intra-class correlation coefficient between the quantification of the two readers was ranged from 0.6 and 0.8. The intra-class correlation coefficient between the reference reviewer and the independent readers with 5 and 10 years of experience ranged from 0.6 to 0.7 and from 0.6 to 0.9, respectively. 
Table 3 shows the results of ROC curve analysis for identification of the optimum cut-off value for peak enhancement, AUC, AUCWI, and AUCWO to differentiate predominantly inflammatory or fibrotic strictures among patients with CD with high sensitivity (77.8 – 86.1) and specificity (85.7 – 100).

Discussion
CD strictures should be classified into (predominantly) inflammatory or fibrotic (Peyrin-Biroulet et al. 2012). In this prospective study we found that inflammatory ileal strictures may be differentiated from fibrotic strictures based on different kinetic parameters calculated from the time-intensity curve after microbubble contrast agent injection including peak enhancement and the AUC, AUCWI, AUCWO. We identified different cut-off values to differentiate inflammatory from fibrotic ileal strictures with high sensitivity and specificity even though patients with inflammatory strictures revealed a wide range of values for each of these semi-quantitative parameters. The wide range of values of different kinetic parameters observed in patients with inflammatory strictures was likely related to the lineary scale employed for the quantitative analysis of echo-signal intensity and to the variable grade of inflammation within the bowel wall in patients undergoing different pharmacologic treatment. On the other hand the range of values of different kinetic parameters was more narrow in patients with fibrotic strictures likely due to the more uniform level of mural fibrosis.  
We observed a very high quality of fit between the echo power signal and the theoretical curve both in responders and non-responders, which ensured a reliable quantitative analysis. Our study did not confirm the results of previous studies in which the time to peak enhancement was found lower in patients with inflammatory strictures (Prassopoulos et al. 2001). In this study we started the time recording from the visualization of microbubbles in the scanning plane instead from the microbubble injection time. This eliminates the influence of the microbubble arrival time, which may be quite different in patients with similar CD activity principally due to the different cardiac output.
In our study, we found also that the visual analysis score of the bowel wall contrast enhancement after microbubble injection revealed a weak correlation with the endoscopy grading. Likely, this low grade of correlation was determined by the presence of transmural contrast enhancement in most of patients in our series, both with inflammatory and fibrotic strictures, due to a mixture of acute inflammation and fibrosis which usually coexist in the same stenotic segment. This was due to the high sensitivity of US contrast-specific techniques to the microbubble nonlinear signal since even the fibrotic ileal loops may retain an high level of vascularity after microbubble injection expressed by the evidence of transmural contrast enhancement. 
According to the results of our study, the quantification of the small bowel wall vascularity after microbubble contrast agent injection may provide a reliable index about the existence of mural fibrosis. We suggest that use of quantitative analysis of CEUS cine-clips should be used routinely in clinical practice to assess disease activity as shown in our study, and as in previous literature (Liu et al. 2016; Medellin-Kowalewski et al. 2016).  According to the results of our study, CEUS might become a useful imaging modality for assessing the existence of mural fibrosis in patients with CD, alternative to CT or MR imaging and for monitoring the efficacy of specific medical therapy in reducing bowel wall vascularity related to neoangiogenesis through quantitative analysis of echo-signal intensity after microbubble injection. In addition to CEUS, elastography-derived bowel wall shear wave velocity might be used to differentiate acutely inflamed from fibrotic intestine (Dillman et al. 2013 and 2014). 
It is highly likely that these results can be extrapolated to  other ultrasound system with different setting and contrast specific techniques. Nevertheless, a wider clinical translation is needed, while the assessment of the universe validity of CEUS in this clinical setting should include microbubble contrast agents other than SonoVue.
Our study had some limitations. First, in most patients the reference standard to classify the nature (inflammatory vs fibrotic) of the ileal stricture consisted in mucosal deep biopsy instead on being based on the surgical resected specimen. Second, being an observational study, there was variability of pharmacologic treatment, including the use of corticosteroids, which could represent a confounding factor. Third, CEUS was performed only in the terminal ileal loop and it could be possible that other ileal segments were more or less affected with a more evident change in the kinetic parameter. A further limitation was that we used our own data to set the tresholds that we tested for sensitivity and specificity which may overestimate our results. Finally, calculations of CEUS data were performed in arbitrary lineary units from a single machine and are not necessarily interchangeable with those found in other US equipment.  
In conclusion, the quantitative analysis of small bowel wall contrast enhancement after microbubble contrast agent injection may differentiate inflammatory from  fibrotic ileal strictures in patients with CD.
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Table 1 - Patient characteristics – Responders vs Non-responders


age, years mean (range)                                           42.2 ± 12.22 (15 – 65)gender, male / female                                                40 / 25body mass index, mean (range)                                 24.67 (15.59- 42.72)                       duration of disease, years                                          1 – 10 (mean, 6 years)location of disease                                                      ileum, colonileum  (number of patients)                                         56ileum - colon                                                               9pharmacologic therapyCorticosteroids                                      15Biologic drug + corticosteroids                30adalimumab                                           5infliximab                                               15

Note: - Patient characteristics.  


Table 2  – Values of different kinetic parameters between Inflammatory from Fibrotic Bowel Strictures
	Inflammatorymean ± SD(range)	Fibroticmean ± SD(range)	P
Peak enhancement	35486.19 ± 41274.45(1818.3 – 153539.7)	6252.33 ± 5504.85(1608.09 – 20746.6)	.004
Rise time *	8 ± 2.64(5.46 – 14.81)	8.89 ± 4.48(5.64 – 18.72)	0.83
Time to peak enhancement	10.31 ± 2.85(7.47 - 17.51)	12.15 ± 4.18(7.12 – 20.53)	0.07
Wash-in rate	7608.01 ± 8269.18(281.26 – 27177.62)	1374.89 ± 1459.44(260 – 5095.31)	.002
Wash-out rate	2000.58 ± 2102.51(75.24  – 6190.8)	549.23 ± 581.82(87.52 - 2129.14)	.34
Wash-in perfusion index	23467.09 ± 27421.67(1196.01 – 102648.1)	4040.96 ± 3465.17(1035.68 – 13122.18)	.004
AUC 	749519.4 ± 1013580.3(30332.09 - 3944829)	89787.32 ± 53819.83(31338.93 – 221520.9)	.003
AUCWI	183705.74 ± 237930.64(10702.78 – 958899.8)	30993.2 ± 19454.07(9489.53 – 75378.45)	.008
AUCWO	573844.23 ± 772133.04 (19629.31 - 2985930 )	61930.89 ± 36181.69 (21849.39 – 146142.4)	.001



Note: Average values of percent change = Post – Pre x 100 / Pre, where Pre and Post mean the linear value of each kinetic parameter respectively before and six weeks after the beginning of the pharmacologic treatment
* expressed in seconds. All the other parameters are expressed in linear arbitrary units
AUC = area under the whole time-intensity curve, 
AUCWI = AUC during wash-in
AUCWO = AUC during wash-out 
CI= Confidence Intervals
Table 3  – Areas under ROC curve, sensitivity, and specificity of percent change to differentiate responders from non-responders 
	AUC	Cut-off value	Sensitivity	Specificity
Peak enhancement	0.74(0.60 – 0.87)	≥ 11831	64.52	89.47
Rise time	0.74(0.60 – 0.87)	≥ 7.4	54.84	42.11
Time to peak enhancement	0.48(0.30 – 0.65)	≥ 9.55	54.84	26.32
Wash-in rate	0.34(0.17 – 0.52)	≥ 1152	80.65	57.89
Wash-out rate	0.76(0.62 – 0.89)	≥ 546.9	45.16	73.68
Wash-in perfusion index	0.57(0.40 – 0.74)	≥ 3750	64.52	42.11
AUC 	0.74(0.60 – 0.87)	≥ 28347	58.6	100
AUCWI	0.75(0.61 – 0.88)	≥ 66843	64.52	89.47
AUCWO	0.72(0.58 – 0.86)	≥ 63337	74.19	73.68

Note: The areas under the ROC curve produced by the different cut-off values of the percent increase of area under the whole time-intensity curve, area under the time-intensity curve during wash-in, and area under time-intensity curve during wash-out. Numbers between brackets are 95% confidence intervals.

AUC = area under time-intensity curve, 
AUCWI = AUC during wash-in
AUCWO = AUC during wash-out 



Figure captions

Fig. 1: Box-plots for the percent change of different kinetic parameters observed in inflammatory (blue box) and fibrotic strictures (red box). The top and the bottom of the boxes are the first and third quartiles, respectively. The length of the box represents the interquartile range including 50% of the values. The line through the middle of each box represents the median. The error shows the minimum and maximum values (range). An outside value (separate point - outliers) is defined as a value that is smaller than the lower quartile minus 1.5 times the interquartile range, or larger than the upper quartile plus 1.5 times the interquartile range. The P values for each comparison are shown over the box plots.  PE= peak enhancement; RT= rise time; TTP=time-to-peak enhancement; WIR=wash-in rate: WOR= wash-out rate; WIPI=washin perfusion index; AUC = area under time-intensity curve; AUCWI = AUC during wash-in; AUCWO = AUC during wash-out; a.u. = arbitrary units; s = seconds; K = 1000

Figure 2a, b. 35-year-old male patient with Crohn’s disease. Inflammatory strictures of the terminal ileal tract. (a) Contrast-enhanced ultrasound scan of the terminal ileal loop with a region of interest manually drawn over the anterior bowel wall (green) and another region of interest drawn over the adjacent mesentery (yellow). (b) The corresponding time-intensity curves (a.u. = arbitrary units; s = seconds) obtained after echo-power quantitation by placing a region of interest over the bowel wall (green) and in the adjacent mesentery (yellow).

Figure 3a, b. 45-year-old male patient with Crohn’s disease. Fibrotic stricture of the terminal ileal tract. (a) Contrast-enhanced ultrasound scan of the terminal ileal loop with a region of interest manually drawn over the anterior bowel wall (green) and another region of interest drawn over the adjacent mesentery (yellow). (b) The corresponding time-intensity curves (a.u. = arbitrary units; s = seconds) obtained after echo-power quantitation  by placing a region of interest over the bowel wall (green) and in the adjacent mesentery (yellow).










1



